December 22, 2020
December 22, 2020 – The U.S. FDA has approved an expanded indication for Vaxchora® (cholera vaccine,
live) oral suspension, manufactured by Emergent Travel Health. The vaccine, which
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
December 21, 2020
December 21, 2020 – The U.S. FDA has granted Emergency Use Authorization (EUA) to Moderna for a vaccine to prevent COVID-19 caused by the SARS-CoV-2 virus in individuals who are least 18 years
December 21, 2020
December 21, 2020 – The U.S. FDA has approved EbangaTM (ansuvimab), manufactured by Ridgeback
Pharmaceuticals, to treat Zaire ebolavirus infection (Ebola) in adults and children. Ebanga is
December 21, 2020
December 21, 2020 – The U.S. FDA has approved an expanded chronic sialorrhea indication for Xeomin®
(incobotulinumtoxinA), manufactured by Merz Pharmaceuticals. Previously approved to
December 21, 2020
December 21, 2020 – The U.S. FDA has approved a new indication for Arcalyst (rilonacept), manufactured by Regeneron. The drug is now indicated for maintenance of remission of deficiency of
December 21, 2020
December 21, 2020 – The U.S. FDA has approved expanded indications for three medications from Vertex
Pharmaceuticals that are indicated to treat cystic fibrosis (CF), with patients selected
December 18, 2020
December 18, 2020 – The U.S. FDA has approved Orgovyx TM (relugolix), manufactured by Myovant
Sciences, as the first oral hormone therapy indicated to treat advanced prostate
December 18, 2020
December 18, 2020 The U.S. FDA has approved a new indication for Tagrisso® (osimertinib),
manufactured by AstraZeneca. The drug is now indicated to provide adjuvant treatment